How We Think - Pharma

These are the posts from the How we think section that have been tagged with Pharma.

To see all tags used in our posts, click here.

'Fake news': battling misinformation in healthcare

Ford Stewart|28th March 2019

Account Executive Ford Stewart explores inaccurate reporting of healthcare innovations and the consequences of fake news for patients, healthcare professionals and the public.

read more

50 questions for delivering an exceptional healthcare brand experience

Zoe Bartley, Jenna Earl, Jiayi Chen|7th March 2019

Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need

read more

The brand strategy revolution

Natasha Cowan, Jenna Earl, Leah Carlisle|22nd February 2019

Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need.

read more

Mobilising the public to combat the antimicrobial resistance crisis

Ford Stewart|11th January 2019

Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines this issue and explores what we could do to spark behaviour change. 

read more

Q&A with Dr Timothy Vollmer, leading MS Neurologist

Blue Latitude Health|11th December 2018

Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face when making treatment decisions, and why patients need to be treated with more efficacious drugs earlier on.

read more

Report: Achieving launch excellence in the challenging healthcare markets of today

Blue Latitude Health|10th December 2018

Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging markets.

read more

The outlook for oncology marketing

Fred Bassett, David Cooney|2nd October 2018

Co-founder and Head of Strategy Fred Bassett and Senior Consultant David Cooney give their expert views in the latest MM&M 'Oncology Marketing Perspectives' eBook. Dowload it now to find out what's next for the cancer sector. 

read more

Genetic counsellors: the new healthcare influencers?

Natasha Cowan|28th August 2018

Blue Latitude Health explores the relationship between physicians and genetic counsellors, and the impact this has on turning precision medicine into a reality for oncology patients.

read more

Mastering the precision medicine opportunity

David Cooney|16th August 2018

The rise of precision medicine will transform the pharma business model, challenging the way we commercialise therapies. BLH Senior Consultant and precision medicine expert David Cooney, reveals how you can plan for this change.

read more

Trending: using social media to understand your pharma market

Jiayi Chen|25th June 2018

Senior Associate Consultant Jiayi Chen explains how you can use social media to get under the skin of customers and your competition.

read more